Manufacturing and Production

Showing 15 posts of 5860 posts found.

Five capabilities of centered leadership

February 3, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Caroline Webb, Joanna Barsh, Josephine Mogelof, McKinsey & Company, leadership

The business environment has become more demanding: the global financial crisis and subsequent economic downturn have ratcheted up the pressure …

FDA process validation guidelines emphasise risk management

February 1, 2011 Manufacturing and Production FDA, ICH, process validation

The FDA has published the final version of its Guideline on Process Validation, more than two years after the first …

Oxford BioMedica buys decommissioned facility

February 1, 2011 Manufacturing and Production Oxford BioMedica, RecipharmCobra Biologics, manufacturing

Gene therapy specialist Oxford BioMedica has said it plans to acquire a £1.9 million ($3.1m) manufacturing facility from contract manufacturer …

Mitsubishi Tanabe recalls two million injectables

January 28, 2011 Manufacturing and Production Mitsubishi, injectables, recall

Mitsubishi Tanabe Corp has said it will recall two million of its injectable medicines made at a facility in Ashikaga, …

David Jukes promoted to president of Univar Europe

January 25, 2011 Manufacturing and Production David Jukes, John van Osch, manufacturing and production, univar

Chemical distributor Univar has promoted David Jukes to president of its European operations. He replaces John van Osch who is …

Genzyme plans new Belgium facility

January 25, 2011 Manufacturing and Production Belgium, Genzyme, Lumizyme, Myozyme, Pompe disease, Sanofi-Aventis, alglucosidase alfa

US rare disease drug specialist Genzyme, the subject of a hostile takeover offer from France’s Sanofi-Aventis, says that it will …

Bio and clinical plants feature in 2011 FOYA honours

January 25, 2011 Manufacturing and Production MedImmune, Merck & Co, Novartis, Pfizer, Roche, Shire HGT, pharma manufacturing

Three US and three European manufacturing plants have been shortlisted for the annual Facility of the Year awards, with the …

SHL GM Frank Isaksson to speak at the 2011 Injectable Drug Delivery Conference

January 25, 2011 Manufacturing and Production, Medical Communications auto injector, autoinjector, frank isaksson, injectable drug delivery

With a steadily increasing number of biologics coming to market, the demand for auto injectors and similar devices continues to …

Amgen plant will boost Boehringer Ingelheim’s US presence

January 21, 2011 Manufacturing and Production Abgenix, Amgen, Boehringer Ingelheim, Vectibix, panitumumab, pharma manufacturing

Germany’s Boehringer Ingelheim has agreed to buy a development and manufacturing facility in Fremont, California, from leading biotechnology firm Amgen. …

Pharma manufacturing news in brief

January 21, 2011 Manufacturing and Production Cambrex, Faron Pharmaceuticals, McNeil Consumer Healthcare, NextPharma Technologies, Rentschler Biotechnologie, Sandoz, ShangPharma, Sun European Partners, Teva Pharmaceuticals USA, Unilife Corp

Another J&J recall in the US, plus a round-up of product recalls, acquisitions, facility updates and new contracts in the …

Penn Pharma appoints Wyeth’s Edward Rowland

January 20, 2011 Manufacturing and Production, Research and Development Edward Rowland, Penn Pharma, appointment, manufacturing and production, research and development

Edward Rowland has joined Wales-based pharmaceutical drug developer and manufacturer Penn Pharma as head of operational analytical services. He moves …

Astellas breaks ground on $95m antibody facility

January 20, 2011 Manufacturing and Production Agensys, Astellas, antibodies, antibody

Astellas has broken ground on a $95 million R&D and manufacturing facility in Santa Monica, USA, that will also serve …

Sanofi ‘considering’ raising Genzyme offer

January 19, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, pharma mergers and acquisitions

Sanofi-Aventis could be willing to raise its offer to $76 a share to buy the US biotech firm Genzyme, according …

BMS and Sanofi recall 64 million Avalide tablets

January 18, 2011 Manufacturing and Production Avalide, Avapro, Bristol-Myers Squibb, GMP, Good Manufacturing Practice, Sanofi-Aventis, hypertension, irbesartan

Bristol-Myers Squibb and Sanofi-Aventis have started another massive recall of their antihypertensive product Avalide because a manufacturing defect could affect …

Shire says new plant will add to Replagal, Vpriv capacity

January 17, 2011 Manufacturing and Production Cerezyme, Replagal, Shire, Vpriv

UK drugmaker Shire has completed construction of a new manufacturing facility for its orphan disease drugs Replagal and Vpriv, and …
The Gateway to Local Adoption Series

Latest content